baber/WOPTO huggingface dataset:
Patent JP-2001523319-A (JP)
Title: 熱可塑性ジャケットを備えた空気ラチェットハンド工具
IPC: F01C13/02
Filed: 1999-03-01
Abstract: (57)【要約】
空気ラチェットハンド工具は軸線方向の空気入口路１９を備えた、細長い、全体的に円筒状のハンドル部分１６を有し、また各々が空気モータ１５と連通した、２つの縦方向に延在して形成された溝３１、３２を備えた外面を有している。熱可塑性のあるグリップジャケット４０が該ハンドル部分１６をカバーし、かつ該溝３１、３２と協動して、それらの間に２つの放出空気路５０、５１を形成し、該放出路はハンドル部分の遠端部５２を出口としている。該ジャケットにおける縦方向のリブ４６−４８が半径方向内側へ突出し、ハンドル部分における縦方向の凹所３１、３２と係合して相対的な回転運動を防止し、また該ハンドル部分上のラグ３８が該ジャケットにおける開口の中を貫通し、相対的な軸線方向運動を防いでいる。
Patent JP-2001521474-A (JP)
IPC: B31B50/00
Filed: 1998-04-15
Abstract: A method for obtaining dimensionally structurally stable objects, in particular disposable containers, from a flexible film rewindable on a reel, comprising the steps of preparing a flexible film rewindable on a reel, which, at least in those regions which in the obtained object are required to be substantially rigid, is associated with a structurally transformable substance inert with respect to the film and at least one passive activator therefore, forming an object from the film prepared in this manner, and during any one stage in a formation of the object, administering an energy compatible with the activator to start a structural transformation reaction of the substance and convert the regions from flexible to substantially rigid.
Patent JP-2001523248-A (JP)
IPC: A61P35/00
Filed: 1998-04-14
Abstract: Disclosed are: aqueous parenteral formulations for the treatment of cancer tumors comprising 1,2,4-benzotriazine 1,4-dioxides in a citrate buffer; and method of cancer tumor treatment.
Patent JP-2001526605-A (JP)
Title: 車輪スリップ制御を有する車両用液圧ブレーキシステムおよびそのようなブレーキシステム用バルブ
IPC: B60T8/34
Filed: 1998-05-20
Abstract: (57)【要約】
本発明は、アンチスリップ車輪制御を有する車両のブレーキシステムに関する。このブレーキシステムは、二次回路と一次回路との間に、いわゆる充填バルブすなわち不可逆バルブ（５）を有している。ブレーキ装置を圧力媒体で充填するために両方の回路は最初排出されるが、二次回路は開成している不可逆バルブ（５）を介して排出される。本発明によれば、このバルブは、ブレーキが最初に作動された場合に有効になり、その点で一次回路に圧力の形成がなされるブロック装置（２２、３０）を設けられている。ブロック装置は、バルブ閉成部材（１）をバルブ座体（２）に維持するので、不可逆バルブは通常の操作中において閉成されている。これは、ブレーキが使用されている場合に二次回路に生成されるいかなる負の圧力をも阻止する。
Patent NZ-219582-A (NZ)
Title: Vertical casting of metal: mould constructed of solid material having a resistivity higher than 5#m##l#/cm
Inventor: VIVES C
IPC: B22D11/16
Filed: 1987-03-11
Abstract: The invention relates to an apparatus for regulating the level of the line of contact of the free surface of the metal with the mould in vertical casting. It comprises a mould formed by a material having a level of resistivity of higher than 5  mu  omega .cm, surrounded by an annular coil in which at least one alternating electrical current flows. It finds application in the casting of metallurgical semi-manufactured products, in particular of aluminium and alloys thereof, such as for example lithium-bearing alloys, and in which there is a wish to have both a cortical zone of virtually zero thickness, a fine grain without the previous addition of refining agents, and an absence of pitting.
Patent NZ-232291-A (NZ)
Title: Hook type refastenable securing system: process for its manufacture
Inventor: THOMAS DENNIS ALBERT
IPC: A44B18/00
Filed: 1990-01-30
Abstract: The invention is a refastenable mechanical fastening system, made of free formed prongs (22) joined to a substrate (24). The prongs (22) taper and are nonperpendicularly oriented relative to the plane of the substrate. Each prong (22) has an engaging means (30) projecting laterally from the periphery of the prong. The free formed prongs are manufactured by the process of depositing liquid material onto a moving substrate, stretching the liquid material in a direction parallel to the plane of the substrate and severing the stretched material to form the distal end and engaging means of the prong. The advantageous usage of the fastening system in an article of manufacture, such as a disposable absorbent garment, specifically a diaper, is also disclosed.
Patent NZ-232300-A (NZ)
Title: Forming tube collar for hydraulic connection using precessing former
Inventor: BADOUREAUX JEAN PIERRE
IPC: F16L19/028
Filed: 1990-01-30
Abstract: This method aims to make a tight joint for a rigid pipe of the type comprising an internally shouldered nut (4) engaged on the pipe (2) to be joined, a collar (2a) provided at the end to be joined of this pipe (2) and making the nut (4) be captured by this pipe and a threaded fitting (3) integral with the opening of the device or other component to which this pipe (2) must be joined and on which the nut (4) is intended to be screwed, the front face (3a) of this fitting (3), against which the collar (2a) of the pipe (2) is applied, having a seal (5) disposed in an annular groove (5a) acting as a housing for it, this method being of the type in which the collar (2a) of the pipe (2) is produced by snap-riveting, its end for joining being gripped, after engagement of the shouldered nut (4), in an opening die (6) having a die cavity shouldered to the profile of the collar (2a) desired. 
<??>The die cavity of the opening die (6) is constituted by a shouldered collet (8) intended to remain captive in the joint, between the collar (2a) and the shouldered nut (4), the cylindrical skirt (8a) of this collet (8) being intended to be disposed between the pipe (2) and the inner shoulder (4a) of the nut (4) while its outer shoulder (8a) is intended to rest on the inner shoulder (4a) of the nut (4). 
<IMAGE>
Patent NZ-240053-A (NZ)
Title: Substituted methylene cyclopentyl-substituted purines and pyrimidines which exhibit antiviral activity
Inventor: ZAHLER ROBERT
IPC: A61K31/513
Filed: 1991-10-01
Abstract: Antiviral activity is exhibited by compounds having the formula <CHEM> and its pharmaceutically acceptable salts. v
Patent NZ-244220-A (NZ)
Title: Dna sequences encoding gelonin, production of an immunotoxin
Inventor: ROSENBLUM MICHAEL GORDON
IPC: C12N15/70
Filed: 1992-09-04
Abstract: The present invention provides the nucleotide sequence for a synthetic gene for the plant toxin gelonin and a process for producing, cloning and expressing this synthetic gene. The DNA sequence for a synthetic gene for gelonin as shown in sequence ID NO. 1. The present invention also provides expression vectors containing the DNA sequences for gelonin and cells transformed with these vectors. In addition, an immunotoxin comprising an antibody of conjugated to the protein gelonin.
Patent NZ-253449-A (NZ)
Title: Monoclonal antibody binding to the c-terminal end of human amylin and kits and assays employing it
Inventor: PHELPS JULIE L
IPC: C07K16/00
Filed: 1993-05-17
Abstract: A monoclonal antibody which binds at the C-terminal end of human amylin, and assays using such monoclonals for the detection of amylin and amylin analogs.
Patent NZ-254752-A (NZ)
Title: Dna fragments encoding melanocyte stimulating hormone receptors, their use in production of encoded polypeptides and diagnostic and therapeutic methods
Inventor: WIKBERG JARL
IPC: A61P25/28
Filed: 1993-08-20
Abstract: Novel DNA fragments encoding novel peptides having properties of melanotropic hormone receptors, especially DNA fragments encoding melanocyte stimulating hormone receptors (MSH receptors), as well as polypeptides which are MSH receptors, are disclosed. The use and engineering of melanotropic hormone receptor DNA and polypeptides for production of monoclonal antibodies for diagnostic and therapeutic purposes, as well as the engineering of drugs, cell lines, vectors and DNA for therapeutic and diagnostic purposes are also disclosed. Also disclosed are methods of therapy and diagnosis of malignant melanoma, skin cancer, vitiligo, pyretic condition, inflammatory condition, nociceptive condition, catatonic condition, impaired memory condition, reduced or increased skin tanning, pigmentation condition, epilepsy and nerve damage, using the DNA fragments, polypeptides and antibodies. Methods for selecting substances which interact with the receptors are also disclosed.
Patent NZ-265956-A (NZ)
Title: Lyospheres containing gonadotropin and compositions thereof
Inventor: SKRABANJA ARNOLD TITUS PHILIP
IPC: A61K9/16
Filed: 1994-04-25
Abstract: PCT No. PCT/EP94/01303 Sec. 371 Date Jun. 5, 1995 Sec. 102(e) Date Jun. 5, 1995 PCT Filed Apr. 25, 1994 PCT Pub. No. WO94/25005 PCT Pub. Date Nov. 10, 1994The invention relates to lyospheres comprising gonadotropin, the preparation thereof, as well as pharmaceutical preparations containing the same.
Patent NZ-298994-A (NZ)
Title: Drug dosage form containing a core having at least two layers, both containing a polymer that forms microscopic gel beads upon hydration but only one contains the drug and an impermeable, insoluble coating containing apertures which provide for the hydration and release of the beads
Inventor: RORK GERALD S
IPC: A61K9/32
Filed: 1995-12-18
Abstract: A device is disclosed for the controlled delivery of a beneficial agent, the device consisting of (i) a core comprising at least two layers, wherein at least one layer comprises a beneficial agent and a polymer which forms microscopic gel beads upon hydration and at least one layer which comprises a polymer which forms microscopic gel beads upon hydration; and (ii) an impermeable, insoluble coating which adheres to and surrounds the core and contains apertures which provide an area for the hydration and release of the microscopic gel beads.
Patent NZ-304330-A (NZ)
Title: Cell growth substrate having at least one perfluorinated polyester, two polymerisable groups and a di-functional linking group
Inventor: MEIJS GORDON FRANCIS
IPC: C08F290/06
Filed: 1996-03-27
Abstract: PCT No. PCT/EP96/01340 Sec. 371 Date Jan. 6, 1998 Sec. 102(e) Date Jan. 6, 1998 PCT Filed Mar. 27, 1996 PCT Pub. No. WO96/31548 PCT Pub. Date Oct. 10, 1996Cell growth substrate polymers are described which comprise a macromonomer of the formula (I): Q-(PFPE-L)n-1-PFPE-Q, wherein n is at least 1.0; each PFPE may be the same or different and is a perfluorinated polyether of the formula (II): -OCH2CF2O (CF2CF2O)x(CF2O)y CF2CH2O-, wherein the CF2CF2O and CF2O units may be randomly distributed or distributed as blocks throughout the chain and wherein x and y may be the same or different such that the molecular weight of the perfluoropolyether is in the range of from 242 to 4000, L is a difunctional linking group; and Q at each end of the macromonomer is the same or different and is a polymerizable group. The cell growth substrate polymers may be used in the production of comeal implants.
Patent NZ-311180-A (NZ)
Title: Nucleotide sequence encoding a peptide having beta-xylosidase activity and use thereof
Inventor: DE GRAAFF LEENDERT HENDRIK
IPC: C12N15/09
Filed: 1996-06-24
Abstract: A nucleotide sequence encoding a peptide having fungal b-xylosidase activity is claimed.  The peptide exhibits at least 40% amino acid identity in the primary structure with the amino acid sequence shown in SEQ ID NO. 1 and/or the nucleotide sequence hybridises under stringent conditions with a nucleotide sequence shown in SEQ ID NO. 1, or a part of the nucleotide sequence has at least 5 contiguous nucleotides encoding an amino acid sequence shown in SEQ ID NO. 1.  Use of a host cell having a b-xylosidase gene, for the production of an xylanolytic enzyme preparation, especially an endoxylanase-containing preparation which is essentially free of b-xylosidase activity, is also claimed.  The host cell may be selected from the genera Aspergillus.
Patent NZ-320772-A (NZ)
Title: Controlled small charge blasting by explosive
Inventor: WATSON JOHN DAVID
IPC: F42B3/00
Filed: 1996-08-02
Abstract: Rock and other hard materials, such as concrete, are fragmented by a controlled small-charge blasting process.  The process is accomplished by pressurizing the bottom of a drill hole in such a way as to initiate and propagate a controlled fracture or propagate any pre-existing fractures near the hole bottom.  A cartridge containing an explosive charge is inserted at the bottom of a short hole drilled in the rock.  The explosive charge is configured to provide the desired pressure in the hole bottom, including, if desired, a strong shock spike at the hole bottom to enhance microfracturing.  The cartridge is held in place or stemmed by a massive stemming bar of high-strength material such as steel.  The explosive can be initiated in a variety of ways including by a standard electric blasting cap. The cartridge incorporates additional internal volume designed to control the application of pressure in the bottom hole volume by the detonating explosive.  The primary method by which the high-pressure gases are contained in the hole bottom until relieved by the opening up of controlled fractures, is by the massive inertial stemming bar which blocks the flow of gas up the drill hole except for a small leak path between the stemming bar and the drill hole walls. This small leakage can be further reduced by design features of the cartridge and of the stemming bar.  The stemming bar is preferably connected to a boom mounted on a carrier. A preferred embodiment incorporates an indexing mechanism to allow both a drill and a small-charge blasting apparatus to be used on the same boom for drilling and subsequent charge insertion and firing operations.  The major features of the method and apparatus are the relatively low-energy of the flyrock and the relatively small amount of explosive required to break the rock.
Patent NZ-330770-A (NZ)
Title: Synthesis of perfluoro aromatic boranes and borates
Inventor: ASKHAM FREDRIC
IPC: C07C17/20
Filed: 1997-10-27
Abstract: A method for synthesizing a halopentafluorobenzene from hexafluorobenzene using a Grignard reagent is described.
Patent NZ-333374-A (NZ)
Title: TIE-2 receptor ligands (TIE ligand-3 and TIE ligand-4) and their uses as antagonists of TIE and for blocking blood vessel growth or preventing tumour growth
Inventor: VALENZUELA DAVID M
IPC: C12N15/85
Filed: 1997-06-19
Abstract: An isolated nucleic acid molecule encoding a member of the TIE ligand family, an antibody which specifically binds TIE ligand-3 or TIE ligand-4 and an antagonist of TIE. Therapeutic compositions of the aforementioned compounds for blocking blood vessel growth, promoting neovascularization, promoting the growth or differentiation of a cell expressing the TIE receptor, blocking the growth or differentiation of a cell expressing the TIE receptor and attenuating or preventing tumor growth in a human.
Patent NZ-337271-A (NZ)
Title: 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives and their use as dopamine autoreceptor (D2) agonists
Inventor: MEWSHAW RICHARD ERIC
IPC: A61K31/4184
Filed: 1998-01-13
Abstract: A compound having the formula I wherein: R1 is hydrogen or alkyl; R2 is hydrogen, alkyl, cyclohexylmethyl or -(CH2)mAr; Ar is phenyl, naphthyl, thienyl, furanyl or pyridinyl, each optionally substituted by one or two substituents selected independently from alkyl, halogen, alkoxy and trifluoromethyl; or NRlR2 is 1, 2, 3, 4-tetrahydroquinolin-1-yl or 1, 2, 3, 4-tetrahydroisoquinolin-2-yl; m is 1-5; n is 1 or 2; R3 is hydrogen or alkyl; Y is hydrogen, halogen, alkyl or alkoxy. These compounds are useful in treating diseases that respond to a dopamine D2 agonist.
Patent NZ-500198-A (NZ)
Title: Broadcast and reception system, and conditional access system
Inventor: BAYASSI MULHAM
IPC: H04N21/6377
Filed: 1997-04-25
Abstract: A conditional access system for a satellite television system includes an entitlement message generator 3004, 3002 and a message receiver 2020 to provide access to the programs output from the television transmitter.  A communications server 3022 is connected directly to the entitlement message generator, the communication of the messages between the generator and the receivers being performed via the communications server.  The entitlement messages are generated in response to a request for entitlement communicated to the generator from the receiver via the communications server on the modem back channel 4002.
Patent NZ-501214-A (NZ)
Title: Using adenovirus subgroup B vectors with deprived tissue tropism for liver cells provided by virus capsid
Inventor: VOGELS RONALD
IPC: A61K35/76
Filed: 1999-11-22
Abstract: A gene therapy method, compounds and medicines are provided for wherein the target cell types are endothelial cells and/or smooth muscle cells. The gene delivery vehicle is provided with a peptide or protein with a tissue tropism for at least smooth muscle cells. The embodiments provide for a virus capsid, wherein the capsid comprises at least one adenovirus and a fragment from another different virus, preferable a subgroup B adenovirus. The treatment is suitable for treating cardiovascular diseases.
Patent NZ-503985-A (NZ)
Title: Isolation and expression of farnesene synthase from peppermint, mentha X piperita, L.
Inventor: CROTEAU RODNEY B
IPC: C12P5/02
Filed: 1998-10-05
Abstract: A cDNA encoding (E)-b-farnesene synthase from peppermint (Mentha piperita) has been isolated and sequenced, and the corresponding amino acid sequence has been determined.  Replicable expression vectors are provided which code for (E)-b-farnesene synthase.
Patent NZ-504934-A (NZ)
Title: Travel route planning optimized in accordance with traveller constraints
Inventor: CARDNO ANDREW
IPC: G06Q10/02
Filed: 2000-06-02
Abstract: A reference database of a plurality of travel data sets is maintained in a reference database, each travel data set representing a travel option from a travel origin to a travel destination and including an origin identifier and a destination identifier.  To plan a travel route, one or more travel preferences and at least one user significance value for one of the preferences, are obtained from a user and the travel data sets are retrieved from the reference database to construct one or more candidate travel plans substantially complying with the required travel route. Penalty values based on the user travel preferences are calculated for the respective travel data sets in the candidate travel plans, and the candidate travel plans are ranked on the basis of the calculated penalty values and displayed in ranked order to the user.
Patent NZ-506635-A (NZ)
Title: Palletizing device with two interacting mobile aprons
Inventor: HESTON STEPHEN L
IPC: B65G57/06
Filed: 1999-02-04
Abstract: A pick and place device (10) includes a lift head (24) and platform (18). Both the lift head (24) and platform (18) include flexible aprons (32, 46). An item layer is constructed on the build platform (18) and the lift head (24) is moved into position over the platform. By slipping the lift head apron under the layer while concurrently pulling from under the layer the build platform apron, support for the layer passes from the build platform to the lift head. The lift head then moves to a place site and the lift head apron is pulled from under the layer and the layer falls from the lift head to the place site.
Patent NZ-507936-A (NZ)
Title: Contaminant reduced fish oil
Inventor: CRAVEN CHARLES WYATT
IPC: A23L1/30
Filed: 1999-05-27
Abstract: Process for the preparation of oil of marine origin with reduced content of polychlorinated dioxins, furans, biphenyls and polycyclic aromatic hydrocarbons. The oil obtainable by the process has combined concentrations of polychloranited dioxins, furans and biphenyls in a range from 0.05 - 6 (ng TEQ/kg oil) and is used in foodstuffs or pharmaceutical formulations.
Patent NZ-509659-A (NZ)
Title: Loudspeakers comprising a resonant panel-form member
Inventor: BANK GRAHAM
IPC: H04R9/02
Filed: 1999-08-24
Abstract: A loudspeaker comprising a resonant panel-form member adapted to produce an acoustic output and a vibration exciting system on the panel-form member and adapted to apply bending wave energy thereto, characterized in that the vibration exciting system is adapted to apply a bending couple to the panel-form member.
Patent NZ-515193-A (NZ)
Title: An autotaxin polypeptide to treat diseases associated with elevated serum glucose lipid or free fatty acid levels
Inventor: KELLY JAMES D
IPC: C07K16/24
Filed: 2000-05-05
Abstract: Autotaxin polypeptide comprising the amino acid residues 45 to 859 of SEQ ID NO: 9, 32 to 858 of SEQ ID NO:2, 49 to 915 of SEQ ID NO:4, 49 to 863 of SEQ ID NO:5 or 36 to 885 of SEQ ID NO:6 are useful for the treatment of decreasing blood glucose, decreasing the insulin dosage needed and for treating conditions associated with elevated serum glucose level, lipid levels or free fatty acid levels.
Patent NZ-515589-A (NZ)
Title: Sound generator and method for manufacturing the same
Inventor: ISHII TATSUYA
IPC: G10L25/48
Filed: 2000-05-24
Abstract: A voice and other sounds to be expressed are selected, the sounds are generated and recorded, the sounds are subjected to spectrum analysis and image processing, the image-processed and displayed results of spectrum analysis are recorded on a recording medium.  By rubbing the printed parts by a finger, sounds are produced.
Patent NZ-520286-A (NZ)
Title: Building sheets with scoring guide grooves or nail head set down indentations
Inventor: GLEESON JAMES ALBERT
IPC: E04C2/30
Filed: 2001-01-19
Abstract: Building sheets with a plurality of grooves indented into a surface of the building sheet to provide a guide for cutting the building sheet along the grooves. The grooves are provided at a depth of less than 25% of the thickness of the sheet such that they do not substantially decrease the strength of the sheet or affect off-groove scoring. Preferably, the grooves are arranged in a regularly repeating pattern and are spaced apart by a standard unit of measurement in order for a cutter to accurately size the building sheet to a precise dimension. A simple scoring knife is preferably used to score the sheet along the grooves, without the need for a straight edge, and the sheet is broken by simply bending the sheet of along the score mark. Thus, a score mark can be made between or across grooves without deflection of the mark into a groove and without breakage of the sheet along a groove when the sheet is bent.
Patent NZ-521430-A (NZ)
Title: Compositions comprising 1-4 antigenic peptide fragments of the Wilms' tumour gene product for treatment or prevention of malignant mesothelioma
Inventor: CHEEVER MARTIN A
IPC: A61K35/76
Filed: 2001-02-22
Abstract: Disclosed are compositions and methods for the diagnosis and therapy of Wilms' tumour antigen-associated cancers, and in particular, mesotheliomas. In particular, methods are provided in addition to, compositions and kits for eliciting immune and T cell responses to Wilms' tumour antigen polypeptide-derived antigenic fragments, and methods for the use of such compositions for diagnosis, detection, treatment, monitoring, and/or prevention of human malignant pleural mesothelioma.
Patent NZ-521880-A (NZ)
Title: Use of a gas mixture comprising oxygen, carbon dioxide and helium for treating tumours in patients
Inventor: GARRETT MICHAEL ERNEST
IPC: A61K49/18
Filed: 1998-04-02
Abstract: A method of treating tumours in a non-human animal is described. The method includes the step of the non-human animal inhaling a medical gas mixture comprising from 20% to 70% oxygen, from 1% to 8% carbon dioxide and the remainder being helium. (62) Divided out of 510101
Patent NZ-523702-A (NZ)
Title: Quinazoline derivatives
Inventor: HENNEQUIN LAURENT FRANCOIS AND
IPC: C07D405/14
Filed: 2001-08-15
Abstract: Disclosed are quinazoline compounds of formula (I), for which the substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of diseases mediated by inhibitors of Src non-receptor tyrosine kinases, such as cancer.